These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 7205652

  • 1. The site of dopamine formation in rat striatum after L-dopa administration.
    Hefti F, Melamed E, Wurtman RJ.
    J Pharmacol Exp Ther; 1981 Apr; 217(1):189-97. PubMed ID: 7205652
    [Abstract] [Full Text] [Related]

  • 2. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [Abstract] [Full Text] [Related]

  • 3. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
    Jackson D, Abercrombie ED, Zigmond MJ.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
    [Abstract] [Full Text] [Related]

  • 4. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Kääriäinen TM, García-Horsman JA, Piltonen M, Huotari M, Männistö PT.
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898
    [Abstract] [Full Text] [Related]

  • 5. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Schneider MB, Murrin LC, Pfeiffer RF, Deupree JD.
    Clin Neuropharmacol; 1984 Mar; 7(3):247-57. PubMed ID: 6435870
    [Abstract] [Full Text] [Related]

  • 6. Transplantation of autologous sympathetic neurons as a potential strategy to restore metabolic functions of the damaged nigrostriatal dopamine nerve terminals in Parkinson's disease.
    Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.
    Brain Res Rev; 2006 Sep; 52(2):244-56. PubMed ID: 16644019
    [Abstract] [Full Text] [Related]

  • 7. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
    Cole DG, Growdon JH, DiFiglia M.
    Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H, Aimi Y, Nagatsu I, Taki K, Kudo M, Arai R.
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [Abstract] [Full Text] [Related]

  • 9. Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism.
    Melamed E, Hefti F, Wurtman RJ.
    Ann Neurol; 1980 Dec; 8(6):558-63. PubMed ID: 6260009
    [Abstract] [Full Text] [Related]

  • 10. The expression of the calcium binding protein calretinin in the rat striatum: effects of dopamine depletion and L-DOPA treatment.
    Mura A, Feldon J, Mintz M.
    Exp Neurol; 2000 Aug; 164(2):322-32. PubMed ID: 10915571
    [Abstract] [Full Text] [Related]

  • 11. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
    Melamed E, Hefti F, Wurtman RJ.
    Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
    [Abstract] [Full Text] [Related]

  • 12. Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions.
    Brannan T, Bhardwaj A, Martinez-Tica J, Weinberger J, Yahr M.
    J Neural Transm Park Dis Dement Sect; 1990 Jan; 2(1):15-22. PubMed ID: 2113388
    [Abstract] [Full Text] [Related]

  • 13. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J, Zhu WM, Stanic D, Finkelstein DI, Horne MH, Henderson J, Lawrence AJ, O'Connor L, Tomas D, Drago J, Horne MK.
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [Abstract] [Full Text] [Related]

  • 14. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 15. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP.
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [Abstract] [Full Text] [Related]

  • 16. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
    Meissner W, Ravenscroft P, Reese R, Harnack D, Morgenstern R, Kupsch A, Klitgaard H, Bioulac B, Gross CE, Bezard E, Boraud T.
    Neurobiol Dis; 2006 Jun; 22(3):586-98. PubMed ID: 16531050
    [Abstract] [Full Text] [Related]

  • 17. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease.
    Nakao N, Shintani-Mizushima A, Kakishita K, Itakura T.
    Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803
    [Abstract] [Full Text] [Related]

  • 18. Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease.
    Rocchitta G, Migheli R, Esposito G, Marchetti B, Desole MS, Miele E, Serra PA.
    J Pineal Res; 2006 Apr; 40(3):204-13. PubMed ID: 16499555
    [Abstract] [Full Text] [Related]

  • 19. Exogenous l-DOPA induce no dopamine immuno-reactivity in striatal astroglias and microglias of adult rats with extensive nigro-striatal dopaminergic denervation.
    Maeda T, Nagata K, Yoshida Y.
    Neurosci Lett; 2008 Mar 15; 433(3):255-8. PubMed ID: 18255227
    [Abstract] [Full Text] [Related]

  • 20. Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism.
    Melamed E, Hefti F, Bitton V, Globus M.
    Neurology; 1984 Dec 15; 34(12):1566-70. PubMed ID: 6504328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.